Dr. Soliman Abdel Kader Fakeeh Hospital Company

SASE:4017 Stock Report

Market Cap: ر.س8.6b

Dr. Soliman Abdel Kader Fakeeh Hospital Future Growth

Future criteria checks 1/6

Dr. Soliman Abdel Kader Fakeeh Hospital is forecast to grow earnings and revenue by 2.5% and 10.2% per annum respectively. EPS is expected to grow by 19.6% per annum. Return on equity is forecast to be 11.3% in 3 years.

Key information

2.5%

Earnings growth rate

19.60%

EPS growth rate

Healthcare earnings growth13.0%
Revenue growth rate10.2%
Future return on equity11.32%
Analyst coverage

Low

Last updated14 Jun 2026

Recent future growth updates

Recent updates

Analysis Article Feb 06

Dr. Soliman Abdel Kader Fakeeh Hospital (TADAWUL:4017) Will Be Hoping To Turn Its Returns On Capital Around

What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common...
Analysis Article Dec 02

Earnings Not Telling The Story For Dr. Soliman Abdel Kader Fakeeh Hospital Company (TADAWUL:4017)

Dr. Soliman Abdel Kader Fakeeh Hospital Company's ( TADAWUL:4017 ) price-to-earnings (or "P/E") ratio of 28.4x might...
Analysis Article Nov 05

Be Wary Of Dr. Soliman Abdel Kader Fakeeh Hospital (TADAWUL:4017) And Its Returns On Capital

What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common...
Analysis Article Aug 06

Returns On Capital At Dr. Soliman Abdel Kader Fakeeh Hospital (TADAWUL:4017) Paint A Concerning Picture

SASE:4017 1 Year Share Price vs Fair Value Explore Dr. Soliman Abdel Kader Fakeeh Hospital's Fair Values from the...
Analysis Article Apr 22

Investors Still Waiting For A Pull Back In Dr. Soliman Abdel Kader Fakeeh Hospital Company (TADAWUL:4017)

With a price-to-earnings (or "P/E") ratio of 36.8x Dr. Soliman Abdel Kader Fakeeh Hospital Company ( TADAWUL:4017 ) may...
Analysis Article Dec 05

Why Investors Shouldn't Be Surprised By Dr. Soliman Abdel Kader Fakeeh Hospital Company's (TADAWUL:4017) 26% Share Price Surge

Dr. Soliman Abdel Kader Fakeeh Hospital Company ( TADAWUL:4017 ) shareholders have had their patience rewarded with a...

Earnings and Revenue Growth Forecasts

SASE:4017 - Analysts future estimates and past financials data (SAR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20284,615438-604883
12/31/20274,148367434324
12/31/20263,473286-1533534
3/31/20263,11325646373N/A
12/31/20253,090290-17454N/A
9/30/20253,034300-147515N/A
6/30/20252,969322-234425N/A
3/31/20252,812287-218450N/A
12/31/20242,791288-89436N/A
9/30/20242,711288-16126N/A
6/30/20242,58627448151N/A
3/31/20242,478280212286N/A
12/31/20232,32728028229N/A
9/30/20232,205311-37280N/A
12/31/20222,012326-138-15N/A
12/31/20211,965334172255N/A
12/31/20201,715203-634N/A
12/31/20191,640301N/A-196N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 4017's forecast earnings growth (2.5% per year) is below the savings rate (15.1%).

Earnings vs Market: 4017's earnings (2.5% per year) are forecast to grow slower than the SA market (7% per year).

High Growth Earnings: 4017's earnings are forecast to grow, but not significantly.

Revenue vs Market: 4017's revenue (10.2% per year) is forecast to grow faster than the SA market (1.2% per year).

High Growth Revenue: 4017's revenue (10.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 4017's Return on Equity is forecast to be low in 3 years time (11.3%).


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/26 18:45
End of Day Share Price 2026/06/25 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Dr. Soliman Abdel Kader Fakeeh Hospital Company is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jassim Al-JubranAljazira Capital Company
Marina MikhailCI Capital Research
Ahmed MoatazEFG-Hermes Research